Quarterly report pursuant to Section 13 or 15(d)

Subsequent Events (Details)

v3.21.2
Subsequent Events (Details) - shares
3 Months Ended
Oct. 15, 2021
Sep. 30, 2021
Subsequent Event [Line Items]    
Common stock issued (in shares)   511,065
Subsequent Event | VaccineCo    
Subsequent Event [Line Items]    
Percentage of equity interest held by Company 60.00%  
Percentage of equity interest remaining with Shareholders 40.00%  
Percentage of development, marketing and sales costs the Company is responsible for 40.00%  
Common stock issued (in shares) 4,000,000